Clariane (KO2) Stock Forecast & Price Target
KO2 Analyst Ratings
There are no analyst ratings in the last 3 months.
KO2 Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| David Cerdan | Kepler Capital | EUR 3.10→EUR 4.70 | hold | 41.31%Upside | Upgraded | 05/07/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| David Cerdan | 05/07/26 | EUR 3.10→EUR 4.70 | hold | 41.31%Upside | Upgraded | Kepler Capital |
Best Analysts Covering Clariane
Copying Anthropic General GB's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +23.40% per trade.
Copying Anthropic General GB's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +23.40% per trade.
Copying Anthropic General GB's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +23.40% per trade.
KO2 Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 1 | 1 | 0 | 0 | 0 |
In the current month, KO2 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. KO2 average Analyst price target in the past 3 months is ―.
KO2 Financial Forecast
KO2 Earnings Forecast
Next quarter’s earnings estimate for KO2 is -EUR 0.13 with a range of ― to ―. The previous quarter’s EPS was -EUR 0.13. Its overall industry beat the EPS estimate 53.85% of the time in the past 12 months.
KO2 Sales Forecast
Next quarter’s sales forecast for KO2 is EUR 2.70B with a range of ― to ―. The previous quarter’s sales results were EUR 2.70B. Its overall industry beat sales estimates 84.62% of the time in the past 12 months.
